On April 5, 2022 Light Chain Bioscience reported The American Association for Cancer Research (AACR) (Free AACR Whitepaper) will host its Annual Meeting April 8-13, 2022 (Press release, Light Chain Bioscience, APR 5, 2022, View Source [SID1234611832]). Light Chain Bioscience is very pleased to have Xavier Chauchet attend in-person.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Xavier will be presenting two posters #3225 and #3283 describing differentiating CD47xPD-L1 bispecific #antibody approaches, NI-2601 & NI-2901.

"NI-2601, an Fc-active CD47xPD-L1 bispecific antibody that selectively targets CD47 on PD-L1-positive tumors" (#3283) will be exposed and presented on April 12 between 1:30-5:00 p.m.

↠ Read 1st poster – Poster section 32 [PDF]:

aacr 2022 ni 2901 cd47xpd l1 bispecific antibody for dual immune checkpoint blockade 2601

"NI-2901, a CD47xPD-L1 bispecific antibody for dual immune checkpoint blockade with fine-tuned affinity to reduce erythrocyte binding and improve biodistribution" (#3225) will be exposed and presented on April 12 between 1:30-5:00 p.m.

↠ Read 2nd poster – Poster section 32 [PDF] :

aacr 2022 ni 2901 cd47xpd l1 bispecific antibody for dual immune checkpoint blockade 2901

Ernest N. Morial Convention Center New Orleans, Louisiana

900 Convention Center Blvd, New Orleans, LA 70130, United States